A longitudinal evaluation of changes in disability and quality of life in a sample of women with migraine

Neurological Sciences

Volumn 32, Issue SUPPL. 1, 2011, Pages

  Raggi, Alberto ^a   Leonardi, Matilde ^a   Giovannetti, Ambra ^a   Curone, Marcella ^a   Bussone, Gennaro ^a   D'Amico, Domenico ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Disability; Health related quality of life; Migraine; SF 36; WHO DAS II

Indexed keywords

ADULT; AGED; ARTICLE; DISABILITY; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MIGRAINE; MIGRAINE WITHOUT AURA; QUALITY OF LIFE; RATING SCALE; SHORT FORM 36; SKILL; SOCIAL BEHAVIOR; WHO DISABILITY ASSESSMENT SCHEDULE II;

ADULT; AGED; DISABILITY EVALUATION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; MIGRAINE DISORDERS; QUALITY OF LIFE; QUESTIONNAIRES; YOUNG ADULT;

EID: 79960133090     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-011-0535-2     Document Type: Article

References (10)

1. Leonardi M, Raggi A, Bussone G, D'Amico D (2010) Healthrelated quality of life, disability and severity of disease in patients with migraine attending to a specialty headache center. Headache 50:1576-1586
2. Raggi A, Leonardi M, Bussone G, D'Amico D (2011) Value and utility of disease-specific and generic instruments for assessing disability in patients with migraine, and their relationships with health-related quality of life. Neurol Sci. doi:10.1007/s10072-010-0466-3
3. Dahlöf C, Loder E, Diamond M, Rupnow M, Papadopoulos G, Mao L (2007) The impact of migraine prevention on daily activities: A longitudinal and responder analysis from three topiramate placebo-controlled clinical trials. Health Qual Life Outcomes 5:56
4. Diener HC, Agosti R, Allais G, Bergmans P, Bussone G, Davies B, Ertas M, Lanteri-Minet M, Reuter U, Sánchez Del Río M, Schoenen J, Schwalen S, van Oene J, TOPMAT-MIG-303 Investigators Group (2007) Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): A randomised, double-blind, placebo-controlled trial. Lancet Neurol 6:1054-1062 (Pubitemid 350123606)
5. Berg J, Stovner LJ (2005) Cost of migraine and other headaches in Europe. Eur J Neurol 12:S59-S62
6. Stovner LJ, Zwart JA, Hagen K, Terwindt GM, Pascual J (2006) Epidemiology of headache in Europe. Eur J Neurol 13:333-345
7. Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders. Cephalalgia 24:S1-S160
8. Apolone G, Mosconi P (1998) The Italian SF-36 health survey: Translation, validation and norming. J Clin Epidemiol 51:1025-1036 (Pubitemid 28527158)
9. Federici S, Meloni F, Mancini A, Lauriola M, Olivetti Belardinelli M (2009) World Health Organisation Disability Assessment Schedule II: Contribution to the Italian validation. Disabil Rehabil 31:553-564
10. D'Amico D, Mosconi P, Genco S, Usai S, Prudenzano AM, Grazzi L, Leone M, Puca FM, Bussone G (2001) The Migraine Disability Assessment (MIDAS) questionnaire: Translation and reliability of the Italian version. Cephalalgia 21:947-952 (Pubitemid 34626030)